Outcome of the Board Meeting held on 14.05.2025 has been duly attached. The matters which are approved duly enclosed in the Outcome of Board Meeting which commenced at 12.30 P.M. and concluded ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors approved the audited financial results for Q4 and full year ended 31st March 2025, along with related disclosures including internal audit report, secretarial compliance report, and related party transactions. The auditor issued a qualified/modified opinion due to two issues: inability to determine fair value of non-current equity investments worth ₹194.76 lakhs (impacting OCI), and actuarial valuation not carried out as required under Ind AS 19. Revenue from operations fell to ₹256.46 lakhs in FY25 from ₹357.02 lakhs in FY24 — a decline of roughly 28%. The company reported a loss after tax of ₹17.99 lakhs for FY25 versus ₹16.82 lakhs loss in FY24. The balance sheet shows very high trade receivables of ₹1,358.18 lakhs against annual revenue of just ₹256.46 lakhs, and total borrowings of ₹988.73 lakhs against equity of ₹388.64 lakhs (debt-to-equity ~2.5x).
Shareholders should note the qualified audit opinion, declining top line, continued losses, stretched receivables, and elevated debt levels — all of which signal weak financial health. The stock may see negative sentiment given the combination of revenue contraction, auditor qualifications, and the long-pending MES contract dispute.